Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Menon

Showing results (401-410 of 510) with videos related to

Pageof 51
Sort By:
Haematology and Blood Transfusion|January 1, 1985
A model scheme of hematopoietic cell differentiation based on multiple marker analysis of leukemia-lymphomas: T cell lineageJ Minowada, H G Drexler, M Menon, et al.
Gynecologic Oncology|May 1, 1994
Protein kinase C-dependent and -independent pathways mediate epidermal growth factor (EGF) effects in human endometrial adenocarcinoma cell line KLEH F Gretz, F Talavera, P Connor, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 25, 2012
Timing of surgery after neoadjuvant long-course chemoradiotherapy in the management of locally advanced rectal cancerI G Panagiotopoulou, D Parashar, R Mezher-Sikafi, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 10, 2026
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With MyelofibrosisAkshanth R Polepally, Aline Goebel, Maulik Patel, et al.
Nature Communications|October 25, 2022
Highly nonlinear dipolar exciton-polaritons in bilayer MoS<sub>2</sub>Biswajit Datta, Mandeep Khatoniar, Prathmesh Deshmukh, et al.
Clinical Pharmacokinetics|March 23, 2016
Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I StudiesAkshanth R Polepally, Sven Mensing, Amit Khatri, et al.
Journal of Vascular Surgery|November 5, 2011
Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculatureJohannes Lammer, Dierk Scheinert, Frank Vermassen, et al.
Cancer Chemotherapy and Pharmacology|March 29, 2017
Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFRWijith P Munasinghe, Rajendar K Mittapalli, Hong Li, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 18, 2018
Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese PatientsJiuhong Zha, Bifeng Ding, Haoyu Wang, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 11, 2025
Safety and Effectiveness of Yttrium-90 Radioembolization in People Living with Human Immunodeficiency VirusKartikeya M Menon, Ricki A Gottlieb, Thomas Marron, et al.
Pageof 51

Showing results (401-410 of 510) with videos related to

Sort By:
Pageof 51
Haematology and Blood Transfusion|January 1, 1985
A model scheme of hematopoietic cell differentiation based on multiple marker analysis of leukemia-lymphomas: T cell lineageJ Minowada, H G Drexler, M Menon, et al.
Gynecologic Oncology|May 1, 1994
Protein kinase C-dependent and -independent pathways mediate epidermal growth factor (EGF) effects in human endometrial adenocarcinoma cell line KLEH F Gretz, F Talavera, P Connor, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 25, 2012
Timing of surgery after neoadjuvant long-course chemoradiotherapy in the management of locally advanced rectal cancerI G Panagiotopoulou, D Parashar, R Mezher-Sikafi, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 10, 2026
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With MyelofibrosisAkshanth R Polepally, Aline Goebel, Maulik Patel, et al.
Nature Communications|October 25, 2022
Highly nonlinear dipolar exciton-polaritons in bilayer MoS<sub>2</sub>Biswajit Datta, Mandeep Khatoniar, Prathmesh Deshmukh, et al.
Clinical Pharmacokinetics|March 23, 2016
Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I StudiesAkshanth R Polepally, Sven Mensing, Amit Khatri, et al.
Journal of Vascular Surgery|November 5, 2011
Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculatureJohannes Lammer, Dierk Scheinert, Frank Vermassen, et al.
Cancer Chemotherapy and Pharmacology|March 29, 2017
Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFRWijith P Munasinghe, Rajendar K Mittapalli, Hong Li, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 18, 2018
Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese PatientsJiuhong Zha, Bifeng Ding, Haoyu Wang, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 11, 2025
Safety and Effectiveness of Yttrium-90 Radioembolization in People Living with Human Immunodeficiency VirusKartikeya M Menon, Ricki A Gottlieb, Thomas Marron, et al.
Pageof 51